THIS CONFERENCE IS FOR YOU
Dermatologists • Family Physicians • Internists • Physician Assistants • Nurse Practitioners • Nurses • Residents
After completing this live activity, participants should be better able to:
- Design treatment options that incorporate biologic therapies into the management of appropriately selected patients with psoriasis.
- Describe the pathophysiology of psoriasis and its co-morbidities.
- Diagnose and treat patients with psoriasis appropriately based on current guidelines.
- Incorporate strategies for use of new therapies aimed at blocking the inflammatory mediators of atopic dermatitis.
- Review topical treatment for atopic dermatitis.
- Design evidence-based, guideline-driven treatment strategies for patients with atopic dermatitis based on severity with the goal of clear or almost clear skin.
- Discuss appropriate treatment strategies for rosacea based on individual signs and symptoms as well as knowledge of indications, efficacy, and risks of available and emerging rosacea therapies.
- Design a comprehensive treatment plan for acne patients based on clinical guidelines, incorporating pharmacologic and non-pharmacologic strategies.
- Discuss the clinical relevance of the most recent research on the etiologies and therapy of acne vulgaris.
- Identify and treat patients with photosensitivity disorders.
Keloids and Scars
- Describe the pathophysiology of keloids.
- Identify characteristics of keloids and first-line treatment options.
Management of Melanoma and Dysplastic Nevi
- Distinguish malignant from non-malignant suspicious neoplasms.
- Discuss available treatment strategies for melanoma at various stages of its progression.
- List the benefits and risks of current agents and techniques commonly used in aesthetic and procedural dermatology.
- Select filler agents suitable for use in treating different facial areas.
- Identify a nonsurgical treatment strategy, including potential use of neuromodulators, to address patient concerns about facial aging.
Accreditation and Designation statements
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
Postgraduate Institute for Medicine designates this continuing education activity for 16 contact hours (1.6 CEUs) of the Accreditation Council for Pharmacy Education.
Continuing Nursing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 16 contact hours. Pharmacotherapy contact hours for Advanced Practice Nurses will be designated on your certificate.
The self-assessment program offered at the 21st Las Vegas Dermatology Symposium is approved by the American Board of Dermatology (ABD) for MOC-D self-assessment points. Please be sure to report completion of any self-assessment programs on your MOC-D table located in your ABD profile (www.abderm.org).
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.